<p>BioRestorative Therapies Inc. announced the closing of a public offering involving the issuance of 14,285,715 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 14,285,715 shares of common stock. The warrants have an exercise price of $0.35 per share, are immediately exercisable, and will expire five years from the date of issuance. The offering raised approximately $5.0 million in gross proceeds, which the company intends to use for clinical trials, pre-clinical research and development, its commercial biocosmeceuticals platform, and general corporate purposes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioRestorative Therapies Inc. published the original content used to generate this news brief on February 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</p>

BRTX

IBBQ

SBIO

<p>BioRestorative Therapies Inc. has successfully closed a public offering, raising approximately $5 million by issuing 14,285,715 shares of common stock and warrants to purchase an equal number of shares at an exercise price of $0.35. The funds will be allocated for clinical trials, pre-clinical research and development, its biocosmeceuticals platform, and general corporate purposes. The warrants are immediately exercisable and will expire in five years.</p>

PUBT

VanEck Biotech ETF

Biorestorative Therapies

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

Invesco Nasdaq Biotechnology ETF

Invesco Biotechnology & Genome ETF

ALPS Medical Breakthrough

BioRestorative Therapies Raises $5 Million in Public Offering with Warrants Exercisable at $0.35